Literature DB >> 8726305

Smoking is a risk factor for osteoporosis in women with inflammatory bowel disease.

J A Silvennoinen1, J K Lehtola, S E Niemelä.   

Abstract

BACKGROUND: Some patients with inflammatory bowel disease have reduced bone mineral density, but the risk factors for osteoporosis in these patients are unclear.
METHODS: To evaluate the effect of smoking and other lifestyle factors on bone mineral density in patients with inflammatory bowel disease, we studied 67 patients with ulcerative colitis, 78 with Crohn's disease, 7 with indeterminate colitis, and 73 healthy control subjects. Bone mineral density of the lumbar spine and the proximal femur was measured, using dual-energy X-ray absorptiometry. Measures of smoking and other lifestyle factors were assessed in an interview.
RESULTS: The female ex- or current smokers with inflammatory bowel disease (n = 38) had lower age- and sex-adjusted Z-scores of bone mineral density than the female patients who had never smoked (n = 34) (Z-scores in the lumbar spine, -0.277 (1.283) (mean (standard deviation)) and 0.487 (1.056), respectively; p = 0.008; and in the femoral neck, -0.626 (1.055) and -0.013 (1.019); p = 0.015). These differences were not explained by the type or treatment of the disease, the menstrual history, or the use of estrogen preparations. In male patients no differences in bone mineral density were found between ex- or current smokers and non-smokers. Coffee drinking and alcohol consumption were not associated with bone mineral density in these patients.
CONCLUSIONS: Smoking is associated with low bone mineral density in women with inflammatory bowel disease. This association is not related to the body mass index, the medical treatment, or the type of disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8726305     DOI: 10.3109/00365529609006412

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  20 in total

1.  Effects of current cigarette smoking on clinical course of Crohn's disease and ulcerative colitis.

Authors:  H S Odes; A Fich; S Reif; A Halak; A Lavy; D Keter; R Eliakim; J Paz; E Broide; Y Niv; Y Ron; Y Villa; N Arber; T Gilat
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

Review 2.  Metabolic bone disease in IBD.

Authors:  I Lopez; A L Buchman
Journal:  Curr Gastroenterol Rep       Date:  2000-08

3.  Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density.

Authors:  M T Abreu; V Kantorovich; E A Vasiliauskas; U Gruntmanis; R Matuk; K Daigle; S Chen; D Zehnder; Y-C Lin; H Yang; M Hewison; J S Adams
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

4.  Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease.

Authors:  Sarah A Bartram; Robert T Peaston; David J Rawlings; David Walshaw; Roger M Francis; Nick P Thompson
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

5.  Fracture risk is increased in Crohn's disease, but not in ulcerative colitis.

Authors:  P Vestergaard; K Krogh; L Rejnmark; S Laurberg; L Mosekilde
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

6.  Genetically Predicted Sex Hormone-Binding Globulin and Bone Mineral Density: A Mendelian Randomization Study.

Authors:  Zihao Qu; Jiuzhou Jiang; Fangkun Yang; Jiawei Huang; Jianqiang Zhao; Shigui Yan
Journal:  Calcif Tissue Int       Date:  2020-10-17       Impact factor: 4.333

7.  Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn's disease.

Authors:  C E Todhunter; A Sutherland-Craggs; S A Bartram; P T Donaldson; A K Daly; R M Francis; J C Mansfield; N P Thompson
Journal:  Gut       Date:  2005-07-11       Impact factor: 23.059

8.  A meta-analysis of the effects of cigarette smoking on bone mineral density.

Authors:  K D Ward; R C Klesges
Journal:  Calcif Tissue Int       Date:  2001-05       Impact factor: 4.333

9.  Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection.

Authors:  Ingolf Schiefke; Andreas Fach; Marcus Wiedmann; Andreas-V Aretin; Eva Schenker; Gudrun Borte; Manfred Wiese; Joachim Moessner
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

10.  Osteoporosis and determinants of bone density in patients with Crohn's disease.

Authors:  R J Robinson; F al-Azzawi; S J Iqbal; T Kryswcki; L Almond; K Abrams; J F Mayberry
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.